Herold Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Herold Advisors's LLY Position: Q2 2026 in Review
Herold Advisors increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $365K and bringing the position to 10,550 shares worth $12.7M. The position accounts for 2.5% of the portfolio, ranked #4.
Herold Advisors first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Herold Advisors held 10,550 shares of Eli Lilly worth $12.7M as of Q2 2026.
- Herold Advisors bought 357 Eli Lilly shares in Q2 2026, an estimated $365K.
- Eli Lilly made up 2.5% of Herold Advisors's portfolio in Q2 2026, its #4 holding.
- Herold Advisors first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Herold Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.